{"id":9752,"date":"2023-09-06T07:55:58","date_gmt":"2023-09-06T07:55:58","guid":{"rendered":"https:\/\/prueba.ibima.eu\/?post_type=project&p=9752"},"modified":"2025-11-25T15:32:44","modified_gmt":"2025-11-25T15:32:44","slug":"aa-24","status":"publish","type":"project","link":"https:\/\/ibima.eu\/es\/project\/aa-24\/","title":{"rendered":"AA-24"},"content":{"rendered":"\n[et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.20.4″ _module_preset=\u00bbdefault\u00bb background_image=\u00bbhttps:\/\/ibima.eu\/wp-content\/uploads\/2023\/04\/FotoWeb-min-1000×500-1.jpg\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.20.4″ _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb250px||30px||false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.20.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.24.0″ _module_preset=\u00bbdefault\u00bb header_font=\u00bbPoppins|700|||||||\u00bb header_text_align=\u00bbcenter\u00bb header_text_color=\u00bb#FFFFFF\u00bb header_font_size=\u00bb40px\u00bb header_2_font=\u00bbPoppins|700|||||||\u00bb header_2_text_color=\u00bb#FFFFFF\u00bb header_2_font_size=\u00bb46px\u00bb global_colors_info=\u00bb{}\u00bb]

Riesgo Vascular y Enfermedades Cr\u00f3nicas<\/h1>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.20.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#235b78″ custom_padding=\u00bb30px||30px||true|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.20.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.20.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.20.4″ _module_preset=\u00bbdefault\u00bb header_3_font=\u00bbPoppins|700|||||||\u00bb header_3_text_color=\u00bb#FFFFFF\u00bb header_3_font_size=\u00bb34px\u00bb global_colors_info=\u00bb{}\u00bb]

Lineas de Investigaci\u00f3n<\/h3>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.20.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#d3d6dd\u00bb custom_margin=\u00bb||||true|false\u00bb custom_padding=\u00bb50px||50px||true|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row use_custom_gutter=\u00bbon\u00bb gutter_width=\u00bb2″ _builder_version=\u00bb4.20.4″ _module_preset=\u00bbdefault\u00bb width=\u00bb70%\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.20.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.20.4″ _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#235b78″ text_font_size=\u00bb16px\u00bb text_line_height=\u00bb2.1em\u00bb global_colors_info=\u00bb{}\u00bb]01.<\/strong><\/span>Factores de riesgo vascular y enfermedad cardiovascular.\n02.<\/strong><\/span>Diabetes melitus tipo 2\n03.<\/strong><\/span>Hipertensi\u00f3n arterial\n04.<\/strong><\/span>Dislipemia\n05.<\/strong><\/span>Enfermedades cr\u00f3nicas complejas\n06.<\/strong><\/span>Cronicidad y fragilidad\n07.<\/strong><\/span>Pacientes pluripatol\u00f3gicos[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.20.4″ _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb50px||50px||true|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb2_3,1_3″ use_custom_gutter=\u00bbon\u00bb gutter_width=\u00bb2″ make_equal=\u00bbon\u00bb _builder_version=\u00bb4.20.4″ _module_preset=\u00bbdefault\u00bb width=\u00bb90%\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb2_3″ _builder_version=\u00bb4.20.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_tabs active_tab_background_color=\u00bb#105e7c\u00bb inactive_tab_background_color=\u00bb#41a7d4″ active_tab_text_color=\u00bb#FFFFFF\u00bb _builder_version=\u00bb4.25.1″ _module_preset=\u00bbdefault\u00bb tab_text_color=\u00bb#FFFFFF\u00bb border_color_all=\u00bb#41a7d4″ global_colors_info=\u00bb{}\u00bb][et_pb_tab title=\u00bbProyectos de investigaci\u00f3n\u00bb _builder_version=\u00bb4.24.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_section global_module=\"26081\"][\/et_pb_section][\/et_pb_tab][et_pb_tab title=\u00bbEstudios cl\u00ednicos\u00bb _builder_version=\u00bb4.24.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_section global_module=\"26077\"][\/et_pb_section][\/et_pb_tab][et_pb_tab title=\u00bbPublicaciones cient\u00edficas\u00bb _builder_version=\u00bb4.24.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_section global_module=\"26075\"][\/et_pb_section][\/et_pb_tab][et_pb_tab title=\u00bbOfertas tecnol\u00f3gicas\u00bb _builder_version=\u00bb4.25.1″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_section global_module=\"38289\"][\/et_pb_section][\/et_pb_tab][et_pb_tab title=\u00bbRegistros de propiedad industrial\u00bb _builder_version=\u00bb4.25.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_tab][\/et_pb_tabs][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.20.4″ _module_preset=\u00bbdefault\u00bb border_width_left=\u00bb1px\u00bb border_color_left=\u00bbrgba(67,165,211,0.32)\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_blurb title=\u00bbMiembros\u00bb use_icon=\u00bbon\u00bb font_icon=\u00bb||fa||900″ icon_color=\u00bb#43a5d3″ icon_placement=\u00bbleft\u00bb _builder_version=\u00bb4.20.4″ _module_preset=\u00bbdefault\u00bb header_font=\u00bbPoppins|600|||||||\u00bb header_text_color=\u00bb#235b78″ header_font_size=\u00bb22px\u00bb module_alignment=\u00bbcenter\u00bb custom_margin=\u00bb||||false|false\u00bb custom_padding=\u00bb|||80px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_blurb][et_pb_divider color=\u00bb#43a5d3″ divider_weight=\u00bb2px\u00bb _builder_version=\u00bb4.20.4″ _module_preset=\u00bbdefault\u00bb width=\u00bb70%\u00bb custom_padding=\u00bb|||80px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_divider][dsm_icon_list _builder_version=\u00bb4.20.4″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb|||80px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][dsm_icon_list_child text=\u00bbInvestigador Responsable\u00bb use_icon=\u00bboff\u00bb use_tooltip=\u00bbon\u00bb tooltip_placement=\u00bbtop\u00bb tooltip_background_color=\u00bb#41a7d4″ tooltip_max_width=\u00bb170px\u00bb _builder_version=\u00bb4.20.4″ _module_preset=\u00bbdefault\u00bb text_font=\u00bbPoppins|600|||||||\u00bb text_text_color=\u00bb#105e7c\u00bb text_font_size=\u00bb20px\u00bb tooltip_font=\u00bb||||||||\u00bb tooltip_text_color=\u00bb#FFFFFF\u00bb tooltip_font_size=\u00bb12px\u00bb global_colors_info=\u00bb{}\u00bb]Ser\u00e1 Investigador de este nivel los Investigadores Responsable que lideren un grupo de investigaci\u00f3n del Instituto y sus Co-IR. Esta categor\u00eda puede incluir investigadores muy excepcionales en su disciplina. [\/dsm_icon_list_child][\/dsm_icon_list][et_pb_blurb title=\u00bbMiguel \u00c1ngel Garc\u00eda Ordo\u00f1ez\u00bb image=\u00bbhttps:\/\/ibima.eu\/wp-content\/uploads\/2024\/07\/MAGarciaOrdonez-1.jpg\u00bb icon_placement=\u00bbleft\u00bb image_icon_width=\u00bb71px\u00bb content_max_width=\u00bb558px\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_font=\u00bbPoppins||||||||\u00bb header_text_color=\u00bb#24a8d7″ body_link_text_color=\u00bb#919191″ custom_padding=\u00bb|||80px|false|false\u00bb border_radii_image=\u00bbon|25%|25%|25%|25%\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]

Correo electr\u00f3nico: <\/strong>miguel.garcia.sspa@juntadeandalucia.es<\/a>
ORCID<\/a>
SCOPUS<\/strong><\/a><\/p>[\/et_pb_blurb][dsm_icon_list _builder_version=\u00bb4.24.0″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb|||80px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][dsm_icon_list_child text=\u00bbCo-Investigador Responsable\u00bb use_icon=\u00bboff\u00bb use_tooltip=\u00bbon\u00bb tooltip_placement=\u00bbtop\u00bb tooltip_background_color=\u00bb#41a7d4″ tooltip_max_width=\u00bb170px\u00bb _builder_version=\u00bb4.24.0″ _module_preset=\u00bbdefault\u00bb text_font=\u00bbPoppins|600|||||||\u00bb text_text_color=\u00bb#105e7c\u00bb text_font_size=\u00bb20px\u00bb tooltip_font=\u00bb||||||||\u00bb tooltip_text_color=\u00bb#FFFFFF\u00bb tooltip_font_size=\u00bb12px\u00bb global_colors_info=\u00bb{}\u00bb]Ser\u00e1 Investigador de este nivel los Investigadores Responsable que lideren un grupo de investigaci\u00f3n del Instituto y sus Co-IR. Esta categor\u00eda puede incluir investigadores muy excepcionales en su disciplina. [\/dsm_icon_list_child][\/dsm_icon_list][et_pb_blurb title=\u00bbJes\u00fas Olmedo Llanes\u00bb image=\u00bbhttps:\/\/ibima.eu\/wp-content\/uploads\/2024\/07\/JOlmedoPrueb.jpg\u00bb icon_placement=\u00bbleft\u00bb image_icon_width=\u00bb71px\u00bb content_max_width=\u00bb558px\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb header_font=\u00bbPoppins||||||||\u00bb header_text_color=\u00bb#24a8d7″ body_link_text_color=\u00bb#919191″ custom_padding=\u00bb|||80px|false|false\u00bb hover_enabled=\u00bb0″ border_radii_image=\u00bbon|25%|25%|25%|25%\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb title_text=\u00bbJOlmedoPrueb\u00bb sticky_enabled=\u00bb0″]

Correo electr\u00f3nico:<\/strong> jesus.olmedo.sspa@juntadeandalucia.es<\/a>
ORCID<\/a>
SCOPUS<\/strong><\/a><\/p>[\/et_pb_blurb][dsm_icon_list _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb|||80px|false|false\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][dsm_icon_list_child text=\u00bbInvestigador\/a S\u00e9nior\u00bb use_icon=\u00bboff\u00bb use_tooltip=\u00bbon\u00bb tooltip_placement=\u00bbtop\u00bb tooltip_background_color=\u00bb#41a7d4″ tooltip_max_width=\u00bb170px\u00bb _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb text_font=\u00bbPoppins|600|||||||\u00bb text_text_color=\u00bb#105e7c\u00bb text_font_size=\u00bb20px\u00bb tooltip_font=\u00bb||||||||\u00bb tooltip_text_color=\u00bb#FFFFFF\u00bb tooltip_font_size=\u00bb12px\u00bb global_colors_info=\u00bb{}\u00bb]Ser\u00e1 Investigador de este nivel los Investigadores Responsable que lideren un grupo de investigaci\u00f3n del Instituto y sus Co-IR. Esta categor\u00eda puede incluir investigadores muy excepcionales en su disciplina. [\/dsm_icon_list_child][\/dsm_icon_list][et_pb_blog posts_number=\u00bb20″ include_categories=\u00bb2483″ show_thumbnail=\u00bboff\u00bb show_content=\u00bbon\u00bb show_author=\u00bboff\u00bb show_date=\u00bboff\u00bb show_categories=\u00bboff\u00bb _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb header_font=\u00bbPoppins|600|||||||\u00bb header_text_color=\u00bb#41a7d4″ header_font_size=\u00bb16px\u00bb body_text_color=\u00bb#105e7c\u00bb body_font_size=\u00bb12px\u00bb custom_padding=\u00bb|||100px|false|false\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_blog][dsm_icon_list _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb|||80px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][dsm_icon_list_child text=\u00bbInvestigador\/a Asistencial Colaborador\/a\u00bb use_icon=\u00bboff\u00bb use_tooltip=\u00bbon\u00bb tooltip_placement=\u00bbtop\u00bb tooltip_background_color=\u00bb#41a7d4″ tooltip_max_width=\u00bb170px\u00bb _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb text_font=\u00bbPoppins|600|||||||\u00bb text_text_color=\u00bb#105e7c\u00bb text_font_size=\u00bb20px\u00bb tooltip_font=\u00bb||||||||\u00bb tooltip_text_color=\u00bb#FFFFFF\u00bb tooltip_font_size=\u00bb12px\u00bb global_colors_info=\u00bb{}\u00bb]Ser\u00e1 Investigador Asistencial Colaborador el Investigador que no re\u00fane la consideraci\u00f3n de Investigador Posdoctoral. Estar\u00e1n adscritos a un Grupo de Investigaci\u00f3n liderado por un IR. Las funciones ser\u00e1n las que le tenga asignada su IR.[\/dsm_icon_list_child][\/dsm_icon_list][et_pb_blog posts_number=\u00bb20″ include_categories=\u00bb1739″ show_thumbnail=\u00bboff\u00bb show_content=\u00bbon\u00bb show_author=\u00bboff\u00bb show_date=\u00bboff\u00bb show_categories=\u00bboff\u00bb _builder_version=\u00bb4.24.0″ _module_preset=\u00bbdefault\u00bb header_font=\u00bbPoppins|600|||||||\u00bb header_text_color=\u00bb#41a7d4″ header_font_size=\u00bb16px\u00bb body_text_color=\u00bb#105e7c\u00bb body_font_size=\u00bb12px\u00bb custom_padding=\u00bb|||100px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_blog][dsm_icon_list _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb|||80px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][dsm_icon_list_child text=\u00bbInvestigadores\/as predoctorales y\/o en formaci\u00f3n\u00bb use_icon=\u00bboff\u00bb use_tooltip=\u00bbon\u00bb tooltip_placement=\u00bbtop\u00bb tooltip_background_color=\u00bb#41a7d4″ tooltip_max_width=\u00bb170px\u00bb _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb text_font=\u00bbPoppins|600|||||||\u00bb text_text_color=\u00bb#105e7c\u00bb text_font_size=\u00bb20px\u00bb tooltip_font=\u00bb||||||||\u00bb tooltip_text_color=\u00bb#FFFFFF\u00bb tooltip_font_size=\u00bb12px\u00bb global_colors_info=\u00bb{}\u00bb]

Los investigadores predoctorales y\/o en formaci\u00f3n ser\u00e1n aquellos investigadores que realizan investigaciones bajo supervisi\u00f3n en una l\u00ednea de investigaci\u00f3n orientada a la resoluci\u00f3n de problemas de salud. Incluye aquellos investigadores que est\u00e1n cursando un doctorado (incluyendo a los contratados R\u00edo Hortega)<\/p>[\/dsm_icon_list_child][\/dsm_icon_list][et_pb_blog include_categories=\u00bb1740″ show_thumbnail=\u00bboff\u00bb show_content=\u00bbon\u00bb show_author=\u00bboff\u00bb show_date=\u00bboff\u00bb show_categories=\u00bboff\u00bb _builder_version=\u00bb4.24.0″ _module_preset=\u00bbdefault\u00bb header_font=\u00bbPoppins|600|||||||\u00bb header_text_color=\u00bb#41a7d4″ header_font_size=\u00bb16px\u00bb body_text_color=\u00bb#105e7c\u00bb body_font_size=\u00bb12px\u00bb custom_padding=\u00bb|||100px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_blog][\/et_pb_column][\/et_pb_row][\/et_pb_section]\n","protected":false},"excerpt":{"rendered":"

Riesgo Vascular y Enfermedades Cr\u00f3nicasLineas de Investigaci\u00f3n01.Factores de riesgo vascular y enfermedad cardiovascular. 02.Diabetes melitus tipo 2 03.Hipertensi\u00f3n arterial 04.Dislipemia 05.Enfermedades cr\u00f3nicas complejas 06.Cronicidad y fragilidad 07.Pacientes pluripatol\u00f3gicos

\n\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t

No se encontraron resultados<\/h2>\n\t

La p\u00e1gina solicitada no pudo encontrarse. Trate de perfeccionar su b\u00fasqueda o utilice la navegaci\u00f3n para localizar la entrada.<\/p>\n<\/div>\n\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div> \n\t\t\t\t<\/div>

\n\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t
\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tSeguridad cardiovascular de 2,4 mg de cagrilintida s.c. en combinaci\u00f3n con 2,4 mg de semaglutida s.c. (CagriSema 2,4 mg\/2,4 mg s.c.) una vez a la semana en participantes con obesidad y enfermedad cardiovascular establecida<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\n\t\t\t\t\t

MIGUEL \u00c1NGEL GARC\u00cdA ORD\u00d3\u00d1EZ – ENSAYO CLINICO CON MEDICAMENTOS – III – NOVO NORDISK A\/S<\/p>\n<\/div><\/div>\t\t\t\n\t\t\t<\/article>\n\t\t\t\t\n\t\t\t

\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tInfluencia en pr\u00e1ctica cl\u00ednica real de dabigatr\u00e1n y acenocumorol en la funci\u00f3n renal de pacientes diab\u00e9ticos de edad avanzada con fibrilaci\u00f3n auricular no valvular y enfermedad renal cr\u00f3nica leve-moderada. Estudio Dadifarec.<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\n\t\t\t\t\t

MIGUEL \u00c1NGEL GARC\u00cdA ORD\u00d3\u00d1EZ – ESTUDIO POSAUTORIZACION INDEPENDIENTE – No aplica – FUNDACION ANDALUZA BETURIA PARA LA INVESTIGACION EN SALUD<\/p>\n<\/div><\/div>\t\t\t\n\t\t\t<\/article>\n\t\t\t\t\n\t\t\t

\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tFibrilaci\u00f3n Auricular No Tratada en Andaluc\u00eda: Screening Tras el Ictus (FANTASTIC)<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\n\t\t\t\t\t

MIGUEL \u00c1NGEL GARC\u00cdA ORD\u00d3\u00d1EZ – ESTUDIO OBSERVACIONAL CON MEDICAMENTOS – No aplica – FUNDACION PARA LA GESTION DE LA INVESTIGACI\u00d3N EN SALUD DE SEVILLA<\/p>\n<\/div><\/div>\t\t\t\n\t\t\t<\/article>\n\t\t\t\t\n\t\t\t

\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tEstudio multic\u00e9ntrico, aleatorizado, doble ciego y controlado con placebo en el que se eval\u00faa el efecto de inclisir\u00e1n en la prevenci\u00f3n de acontecimientos cardiovasculares adversos mayores en pacientes de alto riesgo en prevenci\u00f3n primaria (VICTORION-1)<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\n\t\t\t\t\t

MIGUEL \u00c1NGEL GARC\u00cdA ORD\u00d3\u00d1EZ – ENSAYO CLINICO CON MEDICAMENTOS – III – NOVARTIS PHARMA AG<\/p>\n<\/div><\/div>\t\t\t\n\t\t\t<\/article>\n\t\t\t\t\n\t\t\t

\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tEstudio de resultados cardiovasculares con semaglutida en pacientes con diabetes tipo 2<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\n\t\t\t\t\t

MIGUEL \u00c1NGEL GARC\u00cdA ORD\u00d3\u00d1EZ – ENSAYO CLINICO COMERCIAL – III – NOVO NORDISK A\/S<\/p>\n<\/div><\/div>\t\t\t\n\t\t\t<\/article>\n\t\t\t\t\n\t\t\t

\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tEstudio de fase 3, aleatorizado, enmascarado para el observador y comparado con producto activo, para evaluar la seguridad y la eficacia de mRNA-1010, una vacuna experimental frente a la gripe estacional en adultos de 50 o m\u00e1s a\u00f1os.<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\n\t\t\t\t\t

MIGUEL \u00c1NGEL GARC\u00cdA ORD\u00d3\u00d1EZ – ENSAYO CLINICO CON MEDICAMENTOS – III – PAREXEL INTERNATIONAL, S.L.<\/p>\n<\/div><\/div>\t\t\t\n\t\t\t<\/article>\n\t\t\t\t\n\t\t\t

\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tEstudio ALCALOTIC: La ALCALOsis MeTab\u00f3lica en la Insuficiencia Cardiaca descompensada: prevalencia e influencia en el pron\u00f3stico<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\n\t\t\t\t\t

JESUS OLMEDO LLANES – ESTUDIO NO POSAUTORIZACION – No aplica – SOCIEDAD ESPA\u00d1OLA DE MEDICINA INTERNA<\/p>\n<\/div><\/div>\t\t\t\n\t\t\t<\/article>\n\t\t\t\t<\/div>

\n\t
<\/div>\n\t
<\/div>\n<\/div><\/div><\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t \n\t\t\t\t<\/div>
\n\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t
\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tThe significance of metabolic alkalosis on acute decompensated heart failure: the ALCALOTIC study – CLINICAL RESEARCH IN CARDIOLOGY<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\n\t\t\t\t\t

Trull\u00e0s, JC; Pel\u00e1ez, AI; Bl\u00e1zquez, J; S\u00e1nchez-Biosca, A; L\u00f3pez-Reborio, ML; Salamanca-Bautista, P; Fern\u00e1ndez-Rodr\u00edguez, JM; V\u00e1zquez-Ronda, MA; D\u00e1vila-Ramos, MF; Mendoza-Ruiz-De-Zuazu, H; Morales-Rull, JL; Olmedo-Llanes, J; Llacer, P; Conde-Martel, A – 2024 – 10.1007\/s00392-024-02452-z<\/p>\n<\/div><\/div>\t\t\t\n\t\t\t<\/article>\n\t\t\t\t\n\t\t\t

\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tClinical characterization and detection of subclinical atherosclerosis in subjects with extreme hyperalphalipoproteinemia – CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\n\t\t\t\t\t

Esp\u00edldora-Hern\u00e1ndez, J; D\u00edaz-Antonio, T; Olmedo-Llanes, J; Le\u00f3n, JZ; Rioja, J; Valdivielso, P; S\u00e1nchez-Chaparro, MA; Ariza, MJ – 2024 – 10.1016\/j.arteri.2024.03.005<\/p>\n<\/div><\/div>\t\t\t\n\t\t\t<\/article>\n\t\t\t\t\n\t\t\t

\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tApplication of CMO (capacity, motivation, and opportunity) methodology in pharmaceutical care to optimize the pharmacotherapy in older people living with HIV. DISPIMDINAC project – REVISTA ESPANOLA DE QUIMIOTERAPIA<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\n\t\t\t\t\t

S\u00e1nchez-Y\u00e1\u00f1ez, E; Huertas-Fern\u00e1ndez, MJ; Robustillo-Cortes, MD; Ramos-Guerrero, R; Fern\u00e1ndez-Esp\u00ednola, S; Diaz-Acedo, R; Montero-Martin, V; Morillo-Verdugo, R – 2023 – 10.37201\/req\/021.2023<\/p>\n<\/div><\/div>\t\t\t\n\t\t\t<\/article>\n\t\t\t\t\n\t\t\t

\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tClinical Impact of the Capacity-Motivation-Opportunity Pharmacist-Led Intervention in People Living with HIV in Spain, 2019-2020<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\n\t\t\t\t\t

Morillo-Verdugo, R; Robustillo-Cortes, MD; Navarro-Ruiz, A; Ferrandez, JSR; Esp\u00ednola, SF; Garc\u00eda-Valdecasas, MFP; V\u00e9lez-Diaz-Pallares, M – 2022<\/p>\n<\/div><\/div>\t\t\t\n\t\t\t<\/article>\n\t\t\t\t\n\t\t\t

\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tPrognosis for Mitral Valve Repair Surgery in Functional Mitral Regurgitation_<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\n\t\t\t\t\t

Campos-Arjona, R; Rodr\u00edguez-Capit\u00e1n, J; Mart\u00ednez-Carmona, JD; Lavreshin, A; Fern\u00e1ndez-Romero, L; Melero-Tejedor, JM; Jim\u00e9nez-Navarro, M – 2022<\/p>\n<\/div><\/div>\t\t\t\n\t\t\t<\/article>\n\t\t\t\t\n\t\t\t

\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tApplication of the CMO methodology to the improvement of primary adherence to concomitant medication in people living with-HIV. The PRICMO Project<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\n\t\t\t\t\t

Morillo-Verdugo, R; V\u00e9lez-D\u00edaz-Pallar\u00e9s, M; Garc\u00eda-Valdecasas, MFP; Fern\u00e1ndez-Esp\u00ednola, S; Ferr\u00e1ndez, JSR; Navarro-Ruiz, A – 2021<\/p>\n<\/div><\/div>\t\t\t\n\t\t\t<\/article>\n\t\t\t\t\n\t\t\t

\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tPrognostic Implication of Non-Obstructive Coronary Lesions: A New Classification in Different Settings_<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\n\t\t\t\t\t

Rodr\u00edguez-Capit\u00e1n, J; S\u00e1nchez-P\u00e9rez, A; Ballesteros-Pradas, S; Mill\u00e1n-G\u00f3mez, M; Cardenal-Piris, R; Oneto-Fern\u00e1ndez, M; Guti\u00e9rrez-Alonso, L; Rivera-L\u00f3pez, R; Guisado-Rasco, A; Cano-Garc\u00eda, M; Guti\u00e9rrez-Bedmar, M; Jim\u00e9nez-Navarro, M – 2021<\/p>\n<\/div><\/div>\t\t\t\n\t\t\t<\/article>\n\t\t\t\t\n\t\t\t

\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tToxic Nightlife Relationships, Substance Abuse, and Mental Health: Is There a Link? A Qualitative Case Study of Two Patients<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\n\t\t\t\t\t

Racionero-Plaza, S; Le\u00f3n, JAP; Iglesias, MM; Ugalde, L – 2021<\/p>\n<\/div><\/div>\t\t\t\n\t\t\t<\/article>\n\t\t\t\t\n\t\t\t

\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tTRPM5 rs886277 Polymorphism Predicts Hepatic Fibrosis Progression in Non-Cirrhotic HCV-Infected Patients<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\n\t\t\t\t\t

Resino, S; Fern\u00e1ndez-Rodr\u00edguez, A; Pineda-Tenor, D; G\u00f3mez-Moreno, AZ; S\u00e1nchez-Ruano, JJ; Artaza-Varasa, T; Mu\u00f1oz-G\u00f3mez, MJ; Virseda-Berdices, A; Mart\u00edn-Vicente, M; Mart\u00ednez, I; Jim\u00e9nez-Sousa, MA – 2021<\/p>\n<\/div><\/div>\t\t\t\n\t\t\t<\/article>\n\t\t\t\t\n\t\t\t

\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tMTHFR rs1801133 Polymorphism Is Associated With Liver Fibrosis Progression in Chronic Hepatitis C: A Retrospective Study<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\n\t\t\t\t\t

Pineda-Tenor, D; G\u00f3mez-Moreno, AZ; S\u00e1nchez-Ruano, JJ; Artaza-Varasa, T; Virseda-Berdices, A; Fern\u00e1ndez-Rodr\u00edguez, A; Mendoza, PM; Jim\u00e9nez-Sousa, MA; Resino, S – 2020<\/p>\n<\/div><\/div>\t\t\t\n\t\t\t<\/article>\n\t\t\t\t\n\t\t\t

\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tTranscatheter mitral repair according to the cause of mitral regurgitation: real-life data from the Spanish MitraClip registry_<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\n\t\t\t\t\t

Pascual, I; Arzamendi, D; Carrasco-Chinchilla, F; Fern\u00e1ndez-V\u00e1zquez, F; Freixa, X; Nombela-Franco, L; Avanzas, P; Frutos, AMS; Pan, M; Alvarez, ABC; Hern\u00e1ndez-Antol\u00edn, RA; Ikazuriaga, LA; Cruz-Gonz\u00e1lez, I; Gil, JLD; Juango, MSA; Jofresa, AB; Alonso-Briales, JH; Li, CH; Gonz\u00e1lez, TB; Regueiro, A; Armijo, G; Le\u00f3n, V; Amat-Santos, IJ; Romero, M; Nouche, RT; Fern\u00e1ndez-Golf\u00edn, C; G\u00f3mez, LR; Campos-Arjona, R; Mill\u00e1n, X; Coloma, CG; Sanchis, L; Jim\u00e9nez-Quevedo, P; Mor\u00eds, C; Hern\u00e1ndez-Garc\u00eda, JM; Serra, A; de Prado, AP; Est\u00e9vez-Loureiro, R – 2020<\/p>\n<\/div><\/div>\t\t\t\n\t\t\t<\/article>\n\t\t\t\t<\/div>

\n\t
<\/div>\n\t
<\/div>\n<\/div><\/div><\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t \n\t\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t

No se encontraron resultados<\/h2>\n\t

La p\u00e1gina solicitada no pudo encontrarse. Trate de perfeccionar su b\u00fasqueda o utilice la navegaci\u00f3n para localizar la entrada.<\/p>\n<\/div>\n\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div> \n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\t
    <\/ul>\n\t\t\t\t<\/div>\n\t\t\t<\/div>
  • \n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
    <\/span>Investigador Responsable<\/span><\/div>\n\t\t\t<\/li>Ser\u00e1 Investigador de este […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"project_category":[],"project_tag":[],"class_list":["post-9752","project","type-project","status-publish","hentry"],"acf":[],"yoast_head":"\nAA-24 - Ibima<\/title>\n<meta name=\"description\" content=\"Este grupo de investigaci\u00f3n asociado al instituto desarrolla su trabajo en el \u00e1mbito de Riesgo Vascular y Enfermedades Cr\u00f3nicas\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/es\/project\/aa-24\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AA-24 - Ibima\" \/>\n<meta property=\"og:description\" content=\"Este grupo de investigaci\u00f3n asociado al instituto desarrolla su trabajo en el \u00e1mbito de Riesgo Vascular y Enfermedades Cr\u00f3nicas\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/es\/project\/aa-24\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-25T15:32:44+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/project\\\/aa-24\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/project\\\/aa-24\\\/\",\"name\":\"AA-24 - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"datePublished\":\"2023-09-06T07:55:58+00:00\",\"dateModified\":\"2025-11-25T15:32:44+00:00\",\"description\":\"Este grupo de investigaci\u00f3n asociado al instituto desarrolla su trabajo en el \u00e1mbito de Riesgo Vascular y Enfermedades Cr\u00f3nicas\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/project\\\/aa-24\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/project\\\/aa-24\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/project\\\/aa-24\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Proyectos\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/project\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"AA-24\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AA-24 - Ibima","description":"Este grupo de investigaci\u00f3n asociado al instituto desarrolla su trabajo en el \u00e1mbito de Riesgo Vascular y Enfermedades Cr\u00f3nicas","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/es\/project\/aa-24\/","og_locale":"es_ES","og_type":"article","og_title":"AA-24 - Ibima","og_description":"Este grupo de investigaci\u00f3n asociado al instituto desarrolla su trabajo en el \u00e1mbito de Riesgo Vascular y Enfermedades Cr\u00f3nicas","og_url":"https:\/\/ibima.eu\/es\/project\/aa-24\/","og_site_name":"Ibima","article_modified_time":"2025-11-25T15:32:44+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ibima.eu\/project\/aa-24\/","url":"https:\/\/ibima.eu\/project\/aa-24\/","name":"AA-24 - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"datePublished":"2023-09-06T07:55:58+00:00","dateModified":"2025-11-25T15:32:44+00:00","description":"Este grupo de investigaci\u00f3n asociado al instituto desarrolla su trabajo en el \u00e1mbito de Riesgo Vascular y Enfermedades Cr\u00f3nicas","breadcrumb":{"@id":"https:\/\/ibima.eu\/project\/aa-24\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/project\/aa-24\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/project\/aa-24\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"Proyectos","item":"https:\/\/ibima.eu\/es\/project\/"},{"@type":"ListItem","position":3,"name":"AA-24"}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/project\/9752","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/comments?post=9752"}],"version-history":[{"count":9,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/project\/9752\/revisions"}],"predecessor-version":[{"id":58635,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/project\/9752\/revisions\/58635"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/media?parent=9752"}],"wp:term":[{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/project_category?post=9752"},{"taxonomy":"project_tag","embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/project_tag?post=9752"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}